Rare diseases
Investigational molecules
Locations
Partizanu G. 27d, Kauno M. Sav., 49449 Kaunas, Lithuania
Saules seimos medicinos centras UAB in Kaunas, Lithuania specialises in clinical trials of conditions such as Arteriosclerosis, Hypertriglyceridaemia, Chronic obstructive pulmonary disease, Major depression, and other specialisations. This site conducts important research.
The medical center is at the forefront of research in cardiovascular disease, particularly focusing on atherosclerotic cardiovascular disease (ASCVD) and the role of lipoprotein(a) in patient outcomes. The center's research aims to reduce the risk of coronary heart disease death, myocardial infarction, and the need for urgent coronary revascularization in patients with elevated Lp(a).
Through innovative trials, the center is pioneering new treatments that target specific lipid profiles, offering hope for improved cardiovascular outcomes.
Focusing on the primary prevention of atherosclerotic cardiovascular disease (ASCVD), the center is dedicated to reducing the incidence of major adverse cardiovascular events in high-risk patients. The research evaluates the efficacy of novel therapies in preventing cardiovascular death, non-fatal myocardial infarction, non-fatal ischemic stroke, and urgent coronary revascularization.
By advancing preventive strategies, the center aims to significantly lower the burden of cardiovascular diseases in at-risk populations.
Specializing in the management of atrial fibrillation, the center conducts cutting-edge research to prevent cardioembolic events. The focus is on evaluating the effectiveness of new anticoagulant therapies in reducing the risk of stroke and non-CNS systemic embolism.
Through rigorous clinical trials, the center is committed to improving therapeutic options and outcomes for patients with atrial fibrillation.
Clinical trials currently enrolling participants at this site.
Study of lunsekimig versus placebo in adults with inadequately controlled eosinophilic COPD
LithuaniaStudy of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease
LithuaniaA study to evaluate the effect of orforglipron on cardiovascular health in adults with atherosclerotic cardiovascular disease and/or chronic kidney disease
LithuaniaSafety and Tolerability Study of NBI-1065845 as Additional Treatment for Adults with Major Depressive Disorder
LithuaniaStudy of plozasiran to prevent acute pancreatitis in adults with severe hypertriglyceridemia
LithuaniaAssessment of NBI-1065845 as an Additional Treatment for Adults with Major Depressive Disorder
LithuaniaStudy on Ferric Derisomaltose for Patients with Iron Deficiency and Chronic Heart Failure
LithuaniaStudy comparing ferumoxytol and iron sucrose for treating iron deficiency anemia in children
LithuaniaEvaluating the efficacy and safety of CRD-4730 in patients with heart failure with reduced ejection fraction
LithuaniaA study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)
LithuaniaA study comparing ziltivekimab to placebo in patients with heart failure with mildly reduced or preserved ejection fraction and inflammation
LithuaniaLong-Term Safety Study of Plozasiran for Adults with High Triglycerides
LithuaniaGet verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
